Lab, Laboratory Supervisor (PIT) Schedule: 8:30 am - 5:00 pm jobs in United States
cer-icon
Apply on Employer Site
company-logo

Castle Biosciences, Inc. · 4 hours ago

Lab, Laboratory Supervisor (PIT) Schedule: 8:30 am - 5:00 pm

positionPittsburgh, PA
timeFull-time
remoteOnsite
seniorityEntry, Mid Level
date1+ years exp

Castle Biosciences, Inc. is a growing company recognized as a top workplace in the USA, seeking a full-time Laboratory Supervisor for their Pittsburgh laboratory. The role involves overseeing laboratory operations, ensuring compliance with scientific methodologies and regulatory standards, while providing support and coaching to the laboratory team.

BiotechnologyHealth CareHealth Diagnostics
check
Growth OpportunitiesbadNo H1Bnote

Responsibilities

Supervising day-to-day laboratory operations
Ensuring adherence to quality management system policies and procedures
Monitoring employee productivity
Providing guidance and coaching to support performance and operational excellence

Qualification

Molecular testingLaboratory supervisionQuality management systemsScientific methodologiesCoachingTroubleshootingCommunication

Required

Minimum of a bachelor's degree in science related field
Minimum of 1 (CAP) year of experience in high complexity molecular testing (CAP)
All candidates must be legally authorized to work in the United States

Benefits

25% Bonus Potential
20 Accrued PTO Days Annually + 10 Paid Holidays
401K with 100% Company Match up to 6%
3 Health Care Plan Options + Company HSA Contribution
Company Stock Grant Upon Hire

Company

Castle Biosciences, Inc.

twittertwittertwitter
company-logo
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care.
dateFounded in 2008
location
Friendswood, Texas, USA
people-size501-1000 employees
web-link
http://castlebiosciences.com

Funding

Current Stage
Public Company
Total Funding
$427.33M
Key Investors
BrightEdge FundIndustry VenturesHealthQuest Capital
2020-12-15Post Ipo Equity· $266.8M
2020-06-24Post Ipo Equity· $74M
2019-07-24Series Unknown

Leadership Team

leader-logo
Derek Maetzold
President, CEO and Founder
linkedin

Recent News

GlobeNewswire
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
2026-01-12
GenomeWeb
Testing Growth Spurs Castle Biosciences Full-Year 2025 Preliminary Revenue Gain
2026-01-12
GlobeNewswire
Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
2025-12-17
Company data provided by crunchbase